| Product Code: ETC7075988 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of pregabalin into El Salvador in 2024 continued to be dominated by key exporters such as India, China, Mexico, Spain, and Brazil. Despite a high Herfindahl-Hirschman Index indicating significant market concentration, the compound annual growth rate (CAGR) from 2020 to 2024 was negative at -1.96%. However, there was a notable surge in growth from 2023 to 2024, with a growth rate of 40.96%, suggesting a potential shift or expansion in market dynamics for pregabalin imports in El Salvador.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 El Salvador Pregabalin Market Overview |
3.1 El Salvador Country Macro Economic Indicators |
3.2 El Salvador Pregabalin Market Revenues & Volume, 2021 & 2031F |
3.3 El Salvador Pregabalin Market - Industry Life Cycle |
3.4 El Salvador Pregabalin Market - Porter's Five Forces |
3.5 El Salvador Pregabalin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 El Salvador Pregabalin Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 El Salvador Pregabalin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 El Salvador Pregabalin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in El Salvador |
4.2.2 Growing awareness about the benefits of pregabalin in managing neuropathic pain |
4.2.3 Rise in healthcare expenditure and improved access to healthcare services in the country |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval process for pharmaceutical products in El Salvador |
4.3.2 Competition from alternative pain management therapies |
4.3.3 Price volatility of raw materials used in pregabalin production |
5 El Salvador Pregabalin Market Trends |
6 El Salvador Pregabalin Market, By Types |
6.1 El Salvador Pregabalin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 El Salvador Pregabalin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 El Salvador Pregabalin Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.1.4 El Salvador Pregabalin Market Revenues & Volume, By Neuropathic Pain, 2021- 2031F |
6.1.5 El Salvador Pregabalin Market Revenues & Volume, By Anxiety Disorder, 2021- 2031F |
6.1.6 El Salvador Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 El Salvador Pregabalin Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 El Salvador Pregabalin Market Revenues & Volume, By Fibromyalgia Agents, 2021- 2031F |
6.2.3 El Salvador Pregabalin Market Revenues & Volume, By Anticonvulsants, 2021- 2031F |
6.2.4 El Salvador Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.3 El Salvador Pregabalin Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 El Salvador Pregabalin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 El Salvador Pregabalin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 El Salvador Pregabalin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.5 El Salvador Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
7 El Salvador Pregabalin Market Import-Export Trade Statistics |
7.1 El Salvador Pregabalin Market Export to Major Countries |
7.2 El Salvador Pregabalin Market Imports from Major Countries |
8 El Salvador Pregabalin Market Key Performance Indicators |
8.1 Prescription rates of pregabalin by healthcare providers in El Salvador |
8.2 Patient adherence and compliance rates to pregabalin treatment |
8.3 Number of clinical trials and research studies conducted on pregabalin efficacy and safety in the country |
9 El Salvador Pregabalin Market - Opportunity Assessment |
9.1 El Salvador Pregabalin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 El Salvador Pregabalin Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 El Salvador Pregabalin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 El Salvador Pregabalin Market - Competitive Landscape |
10.1 El Salvador Pregabalin Market Revenue Share, By Companies, 2024 |
10.2 El Salvador Pregabalin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here